Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00380575 · ClinicalTrials.gov registry record · Phase 3

Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

A Phase 3 study of Hyponatremia, sponsored by Cumberland Pharmaceuticals.

Completed
Registry status
Phase 3
Development phase
84
Enrollment target
20
Study locations

NCT00380575 is a Phase 3 study of Hyponatremia that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 84 participants, below the 310-participant average among 3 other Hyponatremia trials with a reported enrollment target (73% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00380575, a Phase 3 study of Hyponatremia, has completed, sponsored by Cumberland Pharmaceuticals.

COMPLETED
Registry status
Phase 3
Development phase
84 participants
Enrollment target
20
Study locations

Study Summary

This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion. The population studied will include patients with euvolemic or hypervolemic hyponatremia.

Conditions Studied

Hyponatremia

Interventions

  • DRUG YM087

Study Locations (20)

California

  • - La Jolla
  • - Los Angeles
  • - Santa Rosa

Arizona

  • - Phoenix
  • - Tuscon

Florida

  • - Miami
  • - Plantation

Missouri

  • - Rolla
  • - St Louis

Alabama

  • - Mobile

Illinois

  • - Springfield

Indiana

  • - Indianapolis

Louisiana

  • - Shreveport

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2000-08
Est. Completion 2003-02
Phase Phase 3

Sponsor

Cumberland Pharmaceuticals

43 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00380575

The ClinicalTrials.gov registry entry for NCT00380575 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 310-participant average among 3 other Hyponatremia trials with a reported enrollment target (73% lower). The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hyponatremia appearing as the primary indexed condition, and to 1 intervention - of which YM087 is the first listed.

NCT00380575 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT00380575 about?

NCT00380575 is a clinical study titled "Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia". This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion. The population studied will include patients with euvolemic or hypervolemic hyponatremia.

What is the current status of trial NCT00380575?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 84 participants. The study started on 2000-08. Estimated completion is 2003-02.

What conditions does trial NCT00380575 study?

This clinical trial studies the following conditions: Hyponatremia.

What interventions are being tested in trial NCT00380575?

The interventions under investigation include: YM087 (DRUG).

Who is sponsoring clinical trial NCT00380575?

This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00380575 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hyponatremia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hyponatremia

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.